US Device Guide

The Cardiac Interventions Today Europe Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.

 

Current Supplement

 

News

 

Study From STS Database Supports Surgery Versus TAVR in Young Adults

January 27, 2020 -- The Society of Thoracic Surgeons (STS) announced study findings showing that open heart surgery remains the best option for young and middle-aged adults wi…

Study From CathPCI Registry Analyzes Trends in Usage and Outcomes of Coronary Atherectomy

January 24, 2020 -- Nirat Beohar, MD, et al conducted a study that sought to assess the trends in usage, interhospital variability, and outcomes with coronary atherectomy (CA)…

CE Mark Approval Extended for BioVentrix’s Revivent TC LIVE Therapy

January 22, 2020 -- BioVentrix, Inc. announced the extension of European CE Mark approval for its Revivent TC transcatheter ventricular enhancement system for heart failure to…

FDA Approves Medtronic's Micra AV to Treat Atrioventricular Block

January 21, 2020 -- Medtronic announced it has received FDA approval of Micra AV, the company’s small pacemaker with atrioventricular (AV) synchrony. Micra AV is indicat…

PREDICT-LAA Trial Enrolls First Patient to Study FEops HeartGuide Computer Simulation Device

January 17, 2020 -- FEops announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. Headquartered in Gent, Belgium, FEops is focused on …

Study Shows More Than Half of United States Clinical Trials Fail to Comply With Law on Reporting Results

January 17, 2020 -- The Lancet announced the publication of a study finding that only 41% of clinical trial results are reported promptly onto the United States trial registry…

BioCardia’s Morph DNA Deflectable Guide Catheter Cleared by FDA

January 14, 2020 -- BioCardia, Inc. announced FDA 510(k) clearance for the Morph DNA deflectable guide catheter used to guide the Helix biotherapeutic delivery system during C…

Enrollment Completed in SafePass 2 Study of Emboline’s Embolic Protection Catheter for TAVR

January 15, 2020 -- Emboline, Inc. announced the completion of enrollment in the company’s SafePass 2 clinical study of the Emboliner embolic protection catheter for use…

Three-Year Findings Published for Mortality of Repeat Revascularizations in the EXCEL Trial

January 15, 2020 -- The 3-year findings from an investigation to determine the incidence and impact on mortality of repeat revascularization after index percutaneous coronary …

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.